TENAX THERAPEUTICS, INC. Current Liabilities
TENAX THERAPEUTICS, INC. (TENX) had Current Liabilities of $8.07 million as of 2026-06-30, per its 10-Q filed 2026-07-31.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesCurrent · last filed 2026-07-31
- 2026-06-30: Liabilities, Current $8.07M.
- 2026-03-31: Liabilities, Current $8.49M.
- 2025-12-31: Liabilities, Current $7.16M.
- 2025-09-30: Liabilities, Current $6.60M.
| Period end | Liabilities, Current | Liabilities, Current as first filed |
|---|---|---|
| 2026-06-30 | $8.07M 10-Q · filed 2026-07-31 | |
| 2026-03-31 | $8.49M 10-Q · filed 2026-05-12 | |
| 2025-12-31 | $7.16M 10-Q · filed 2026-07-31 | |
| 2025-09-30 | $6.60M 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $2.53M 10-Q · filed 2025-08-13 | |
| 2025-03-31 | $2.77M 10-Q · filed 2025-05-14 | |
| 2024-12-31 | $4.69M 10-K · filed 2026-03-10 | |
| 2024-09-30 | $2.56M 10-Q · filed 2024-11-13 | |
| 2024-06-30 | $1.74M 10-Q · filed 2024-08-13 | |
| 2024-03-31 | $2.03M 10-Q · filed 2024-05-14 | |
| 2023-12-31 | $3.59M 10-K · filed 2025-03-25 | $3.59M 10-K · filed 2024-03-28 |
| 2023-09-30 | $602.21K 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $823.84K 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $983.86K 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $1.85M 10-K · filed 2024-03-28 | |
| 2022-09-30 | $689.82K 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $1.45M 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $1.98M 10-Q · filed 2022-05-16 | |
| 2021-12-31 | $1.56M 10-K · filed 2023-03-31 | |
| 2021-09-30 | $1.46M 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $1.18M 10-Q · filed 2021-08-16 | |
| 2021-03-31 | $1.43M 10-Q · filed 2021-05-17 | |
| 2020-12-31 | $2.12M 10-K · filed 2022-03-29 | |
| 2020-09-30 | $1.38M 10-Q · filed 2020-11-16 | |
| 2020-06-30 | $2.19M 10-Q · filed 2020-08-14 | |
| 2020-03-31 | $2.51M 10-Q · filed 2020-05-15 | |
| 2019-12-31 | $2.53M 10-K/A · filed 2021-04-16 | |
| 2019-09-30 | $1.13M 10-Q · filed 2019-11-14 | |
| 2019-06-30 | $938.09K 10-Q · filed 2019-08-14 | |
| 2019-03-31 | $1.01M 10-Q · filed 2019-05-15 | |
| 2018-12-31 | $1.57M 10-K · filed 2020-03-30 | |
| 2018-09-30 | $516.16K 10-Q · filed 2018-11-14 | |
| 2018-06-30 | $792.79K 10-Q · filed 2018-08-14 | |
| 2018-03-31 | $311.04K 10-Q · filed 2018-05-15 | |
| 2017-12-31 | $1.01M 10-K · filed 2019-04-01 | |
| 2017-09-30 | $838.55K 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $2.18M 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $5.04M 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $6.20M 10-K · filed 2018-04-02 | |
| 2016-09-30 | $5.06M 10-Q · filed 2016-11-09 | |
| 2016-06-30 | $5.28M 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $6.24M 10-Q · filed 2016-05-10 | |
| 2015-12-31 | $4.60M 10-K · filed 2017-03-16 | |
| 2015-10-31 | $3.56M 10-Q · filed 2015-12-10 | |
| 2015-07-31 | $3.25M 10-Q · filed 2015-09-09 | |
| 2015-04-30 | $4.52M 10-KT · filed 2016-03-14 | |
| 2015-01-31 | $2.87M 10-Q · filed 2015-03-17 | |
| 2014-10-31 | $3.67M 10-Q · filed 2014-12-15 | |
| 2014-07-31 | $1.90M 10-Q · filed 2014-09-15 | |
| 2014-04-30 | $2.57M 10-KT · filed 2016-03-14 | |
| 2014-01-31 | $3.61M 10-Q · filed 2014-03-17 | |
| 2013-10-31 | $1.48M 10-Q · filed 2013-12-17 | |
| 2013-07-31 | $4.71M 10-Q · filed 2013-09-17 | |
| 2013-04-30 | $1.91M 10-K · filed 2014-07-29 | |
| 2013-01-31 | $1.99M 10-Q · filed 2013-03-18 | |
| 2012-10-31 | $1.35M 10-Q · filed 2012-12-14 | |
| 2012-07-31 | $4.00M 10-Q · filed 2012-09-19 | |
| 2012-04-30 | $3.13M 10-K · filed 2013-06-26 | |
| 2012-01-31 | $5.81M 10-Q · filed 2012-03-15 | |
| 2011-10-31 | $2.10M 10-Q · filed 2011-12-15 | |
| 2011-07-31 | $2.27M 10-Q · filed 2011-09-19 | |
| 2011-04-30 | $2.18M 10-K · filed 2012-07-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |